A review of the safety of ibuprofen for OTC use;MISE AU POINT SUR LA SECURITE DE L'IBUPROFENE A DOSE ANTALGIQUE-ANTIPYRETIQUE

Therapie

Volumn 51, Issue 4, 1996, Pages 458-463

  Moore, N ^a   Noblet, C ^a   Breemeersch, C ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

Aspirin; Drug surveillance; Ibuprofen; NSAIDs; Overdose; Paracetamol; Safety

Indexed keywords

ACETYLSALICYLIC ACID; IBUPROFEN; NAPROXEN; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PIROXICAM; UNCLASSIFIED DRUG;

ADVERSE DRUG REACTION; CONFERENCE PAPER; DATA ANALYSIS; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL TOXICITY; HEADACHE; HUMAN; KIDNEY FAILURE; PEPTIC ULCER; PRIORITY JOURNAL;

ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GASTROINTESTINAL HEMORRHAGE; HUMANS; IBUPROFEN; KIDNEY FAILURE; OVERDOSE; SAFETY;

EID: 0029738797     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (13)

1. Haase W, Fischer M. Statistiche Meta-analyse von multizentrischen eemeerschklinischen Studien mit Ibuprofen im Hinblick auf die Kohortengröße. Zeitschrift Rheumatol 1991; 50 Suppl 1: 77-83.
2. Lesko SM, Mitchell AA. An assessment of the safety of pediatric ibuprofen. A practitioner-based randomized clinical trial. JAMA 1995; 273: 929-933.
3. Furey SA, Waksman JA, Dash BH. Non-prescription ibuprofen: side-effect profile. Pharmacotherapy 1992; 12: 403-407.
4. Kaufman DW, Kelly JP, Sheehan JE et al. Non-steroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding. Clin Pharmacol Ther 1993; 53: 485-494.
5. Weil J, Colin-Jones D, Langman M et al. Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 1995; 310: 827-830.
6. Garcia-Rodriguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 769-772.
7. Langman MJS, Weil J, Wainwright P et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 1075-1078.
8. Mann JFE, Goerig M, Brune K, Luft FC. Ibuprofen as an over-the-counter drug: is there a risk for renal injury? Clin Nephrol 1993; 39: 1-6.
9. Roujeau JC, Guillaume JC, Fabre JP et al. Toxic epidermal necrolysis (Lyell Syndrome). Incidence and drug etiology in France, 1981-1985. Arch Dermatol 1990; 126: 37-42.
10. Guillaume JC, Roujeau JC, Revuz J et al. The drug culprit in 87 cases of toxic epidermal necrolysis (Lyell's syndrome). Arch Dermatol 1987; 123: 1166-1170.
11. Castot A, Netter P, Larrey D et al. Hépatites aux anti-inflammatoires non stéroidiens. Bilan coopératif des Centres Régionaux de Pharmacovigilance pour l'année 1985. Therapie 1988; 43: 229-233.
12. Hall AH, Smolinske SC, Stover B et al. Ibuprofen overdose in adults. Clin Toxicol 1992; 30: 23-37.
13. Halpern SM, Fitzpatrick R, Volans GN. Ibuprofen toxicity: a review of adverse reactions and overdose. Adverse Drug React Toxicol Rev 1993; 12: 201.1-22.